Correction to: SIRT3 activation protects from nabumetone-induced mitochondrial toxicity in adult human cardiomyocytes
Yafei Huang, Hong Liu, Chao Tong, Zhimin Wang, Miaomiao Xu, Mengqi Dong, Rongjia Rao, Xianqiang Wang, Wei Feng, Zhan Hu, Fei Xu, Wei Zhao, Li Wang, Shengshou Hu, Bingying Zhou · 2026
Read Correction to: SIRT3 activation protects from nabumetone-induced mitochondrial toxicity in adult human cardiomyocytes by Yafei Huang, Hong Liu, Chao Tong, Zhimin Wang, Miaomiao Xu, Mengqi Dong, Rongjia Rao, Xianqiang Wang, Wei Feng, Zhan Hu, Fei Xu, Wei Zhao, Li Wang, Shengshou Hu, Bingying Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13309579.txt.
Description
Yafei Huang is first named on a 2026 correction notice for a study of how the pain drug nabumetone can harm heart muscle cells. The study links that harm to energy-center damage, with SIRT3 activation offering protection. Corrected here are only the legends for figures 4 and 5, which were published incorrectly. The notice reprints both figures with their proper legends, covering a prostaglandin pathway test in human heart cells. No results or conclusions change, since the item exists solely to fix those captions.
Catalog record
| CREATOR | Yafei Huang, Hong Liu, Chao Tong, Zhimin Wang, Miaomiao Xu, Mengqi Dong, Rongjia Rao, Xianqiang Wang, Wei Feng, Zhan Hu, Fei Xu, Wei Zhao, Li Wang, Shengshou Hu, Bingying Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4296 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |